The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Recent Advances in Lentiviral Vector Development and Applications
Open accessAbstract
Lentiviral vectors (LVs) have emerged as potent and versatile vectors for ex vivo or in vivo gene transfer into dividing and nondividing cells. Robust phenotypic correction of diseases in mouse models has been achieved paving the way toward the first clinical trials. LVs can deliver genes ex vivo into bona fide stem cells, particularly hematopoietic stem cells, allowing for stable transgene expression upon hematopoietic reconstitution. They are also useful to generate induced pluripotent stem cells. LVs can be pseudotyped with distinct viral envelopes that influence vector tropism and transduction efficiency. Targetable LVs can be generated by incorporating specific ligands or antibodies into the vector envelope. Immune responses toward the transgene products and transduced cells can be repressed using microRNA-regulated vectors. Though there are safety concerns regarding insertional mutagenesis, their integration profile seems more favorable than that of gamma-retroviral vectors (gamma-RVs). Moreover, it is possible to minimize this risk by modifying the vector design or by employing integration-deficient LVs. In conjunction with zinc-finger nuclease technology, LVs allow for site-specific gene correction or addition in predefined chromosomal loci. These recent advances underscore the improved safety and efficacy of LVs with important implications for clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Manno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9873-9880.1998 · Cited by 1,815
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009) · Nature · doi:10.1038/nature07863 · Cited by 1,814
Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J., Pekarik, V., Tiscornia, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1503 · Cited by 1,423
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt.1502 · Cited by 1,341
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Generation of human induced pluripotent stem cells from dermal fibroblasts
Lowry, W. E., Richter, L., Yachechko, R., Pyle, A. D., Tchieu, J., Sridharan, R., Clark, A. T., & Plath, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711983105 · Cited by 1,041
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V., Lee, Y.-L., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1410 · Cited by 999
Mátés, L., Chuah, M. K. L., Belay, E., Jerchow, B., Manoj, N., Acosta-Sanchez, A., Grzela, D. P., Schmitt, A., Becker, K., Matrai, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.343 · Cited by 948
Self-citationOct4-Induced Pluripotency in Adult Neural Stem Cells
Kim, J. B., Sebastiano, V., Wu, G., Araúzo-Bravo, M. J., Sasse, P., Gentile, L., Ko, K., Ruau, D., Ehrich, M., van den Boom, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.023 · Cited by 934
Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845
Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency
Hanna, J., Markoulaki, S., Schorderet, P., Carey, B. W., Beard, C., Wernig, M., Creyghton, M. P., Steine, E. J., Cassady, J. P., Foreman, R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.028 · Cited by 814
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
Sampaolesi, M., Blot, S., D’Antona, G., Granger, N., Tonlorenzi, R., Innocenzi, A., Mognol, P., Thibaud, J.-L., Galvez, B. G., Barthélémy, I., et al. (2006) · Nature · doi:10.1038/nature05282 · Cited by 769
Cd8(+) T-Cell Responses to Adeno-Associated Virus Capsid in Humans
Mingozzi, F., Maus, M. V., Hui, D. J., Sabatino, D. E., Murphy, S. L., Rasko, J. E. J., Ragni, M. V., Manno, C. S., Sommer, J., Jiang, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1549 · Cited by 748
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., Sergi, L. S., Benedicenti, F., Ambrosi, A., Di Serio, C., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1216 · Cited by 701
Qin, X.-F., An, D. S., Chen, I. S. Y., & Baltimore, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232688199 · Cited by 701
Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-1075 · Cited by 676
Gene targeting using zinc finger nucleases
Porteus, M. H., & Carroll, D. (2005) · Nature Biotechnology · doi:10.1038/nbt1125 · Cited by 641
Sampaolesi, M., Torrente, Y., Innocenzi, A., Tonlorenzi, R., D'Antona, G., Pellegrino, M. A., Barresi, R., Bresolin, N., De Angelis, M. G. C., Campbell, K. P., et al. (2003) · Science · doi:10.1126/science.1082254 · Cited by 641
Bartosch, B., Vitelli, A., Granier, C., Goujon, C., Dubuisson, J., Pascale, S., Scarselli, E., Cortese, R., Nicosia, A., & Cosset, F.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305289200 · Cited by 631
Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M., & Torbett, B. E. (1999) · Science · doi:10.1126/science.283.5402.682 · Cited by 624
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine · doi:10.1038/nm1085 · Cited by 620
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
Kafri, T., Blömer, U., Peterson, D. A., Gage, F. H., & Verma, I. M. (1997) · Nature Genetics · doi:10.1038/ng1197-314 · Cited by 605
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A., Kingsman, S. M., Carmeliet, P., & Mazarakis, N. D. (2004) · Nature · doi:10.1038/nature02544 · Cited by 590
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
May, C., Rivella, S., Callegari, J., Heller, G., Gaensler, K. M. L., Luzzatto, L., & Sadelain, M. (2000) · Nature · doi:10.1038/35017565 · Cited by 567
Brown, B. D., Gentner, B., Cantore, A., Colleoni, S., Amendola, M., Zingale, A., Baccarini, A., Lazzari, G., Galli, C., & Naldini, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1372 · Cited by 556
Stegmeier, F., Hu, G., Rickles, R. J., Hannon, G. J., & Elledge, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506306102 · Cited by 532
Self-complementary AAV vectors; advances and applications
McCarty, D. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.171 · Cited by 515
Ralph, G. S., Radcliffe, P. A., Day, D. M., Carthy, J. M., Leroux, M. A., Lee, D. C. P., Wong, L.-F., Bilsland, L. G., Greensmith, L., Kingsman, S. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1205 · Cited by 506
Gene transfer in humans using a conditionally replicating lentiviral vector
Levine, B. L., Humeau, L. M., Boyer, J., MacGregor, R.-R., Rebello, T., Lu, X., Binder, G. K., Slepushkin, V., Lemiale, F., Mascola, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608138103 · Cited by 501
Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
Miyoshi, H., Takahashi, M., Gage, F. H., & Verma, I. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10319 · Cited by 494
Brown, B. D., Venneri, M. A., Zingale, A., Sergi, L. S., & Naldini, L. (2006) · Nature Medicine · doi:10.1038/nm1398 · Cited by 484
Effective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460
Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model
Singer, O., Marr, R. A., Rockenstein, E., Crews, L., Coufal, N. G., Gage, F. H., Verma, I. M., & Masliah, E. (2005) · Nature Neuroscience · doi:10.1038/nn1531 · Cited by 428
Mazarakis, N. D. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2109 · Cited by 426
Modlich, U., Navarro, S., Zychlinski, D., Maetzig, T., Knoess, S., Brugman, M. H., Schambach, A., Charrier, S., Galy, A., Thrasher, A. J., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.179 · Cited by 387
Case, S. S., Price, M. A., Jordan, C. T., Yu, X. J., Wang, L., Bauer, G., Haas, D. L., Xu, D., Stripecke, R., Naldini, L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2988 · Cited by 386
Gene delivery by lentivirus vectors
Cockrell, A. S., & Kafri, T. (2007) · Molecular Biotechnology · doi:10.1007/s12033-007-0010-8 · Cited by 355
Vigna, E., & Naldini, L. (2000) · The Journal of Gene Medicine · doi:10.1002/1521-2254(200009/10)2:5<308::aid-jgm131>3.0.co;2-3 · Cited by 343
Efficient lentiviral transduction of liver requires cell cycling in vivo
Park, F., Ohashi, K., Chiu, W., Naldini, L., & Kay, M. A. (2000) · Nature Genetics · doi:10.1038/71673 · Cited by 323
Sinn, P. L., Sauter, S. L., & McCray, P. B. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302570 · Cited by 322
Kobinger, G. P., Weiner, D. J., Yu, Q.-C., & Wilson, J. M. (2001) · Nature Biotechnology · doi:10.1038/85664 · Cited by 307
Sandrin, V., Boson, B., Salmon, P., Gay, W., Nègre, D., Le Grand, R., Trono, D., & Cosset, F.-L. (2002) · Blood · doi:10.1182/blood-2001-11-0042 · Cited by 305
Stable knockdown of microRNA in vivo by lentiviral vectors
Gentner, B., Schira, G., Giustacchini, A., Amendola, M., Brown, B. D., Ponzoni, M., & Naldini, L. (2009) · Nature Methods · doi:10.1038/nmeth.1277 · Cited by 304
Yoder, A., Yu, D., Dong, L., Iyer, S. R., Xu, X., Kelly, J., Liu, J., Wang, W., Vorster, P. J., Agulto, L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.036 · Cited by 295
Macrophage Tropism of HIV-1 Depends on Efficient Cellular dNTP Utilization by Reverse Transcriptase
Diamond, T. L., Roshal, M., Jamburuthugoda, V. K., Reynolds, H. M., Merriam, A. R., Lee, K. Y., Balakrishnan, M., Bambara, R. A., Planelles, V., Dewhurst, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408573200 · Cited by 290
Optimized large-scale production of high titer lentivirus vector pseudotypes
Sena-Esteves, M., Tebbets, J. C., Steffens, S., Crombleholme, T., & Flake, A. W. (2004) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.08.017 · Cited by 289
Therapeutic gene causing lymphoma
Woods, N.-B., Bottero, V., Schmidt, M., von Kalle, C., & Verma, I. M. (2006) · Nature · doi:10.1038/4401123a · Cited by 288
Biffi, A., De Palma, M., Quattrini, A., Del Carro, U., Amadio, S., Visigalli, I., Sessa, M., Fasano, S., Brambilla, R., Marchesini, S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419205 · Cited by 280
Hematti, P., Hong, B.-K., Ferguson, C., Adler, R., Hanawa, H., Sellers, S., Holt, I. E., Eckfeldt, C. E., Sharma, Y., Schmidt, M., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020423 · Cited by 265
Lentiviral vectors: turning a deadly foe into a therapeutic agent
Trono, D. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301105 · Cited by 263
Biffi, A., De Palma, M., Quattrini, A., Del Carro, U., Amadio, S., Visigalli, I., Sessa, M., Fasano, S., Brambilla, R., Marchesini, S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19205 · Cited by 261
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice
Brown, B. D., Cantore, A., Annoni, A., Sergi, L. S., Lombardo, A., Della Valle, P., D'Angelo, A., & Naldini, L. (2007) · Blood · doi:10.1182/blood-2007-03-078493 · Cited by 252
Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., & Serguera, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606197103 · Cited by 249
VandenDriessche, T., Thorrez, L., Naldini, L., Follenzi, A., Moons, L., Berneman, Z., Collen, D., & Chuah, M. K. L. (2002) · Blood · doi:10.1182/blood.v100.3.813 · Cited by 236
Self-citationIntegration-deficient Lentiviral Vectors: A Slow Coming of Age
Wanisch, K., & Yáñez-Muñoz, R. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.122 · Cited by 222
Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice
Biffi, A., Capotondo, A., Fasano, S., Carro, U. D., Marchesini, S., Azuma, H., Malaguti, M. C., Amadio, S., Brambilla, R., Grompe, M., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28873 · Cited by 221
Targeted Cell Entry of Lentiviral Vectors
Funke, S., Maisner, A., Mühlebach, M. D., Koehl, U., Grez, M., Cattaneo, R., Cichutek, K., & Buchholz, C. J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.128 · Cited by 218
Chang, C.-W., Lai, Y.-S., Pawlik, K. M., Liu, K., Sun, C.-W., Li, C., Schoeb, T. R., & Townes, T. M. (2009) · Stem Cells · doi:10.1002/stem.39 · Cited by 217
Kong, J., Kim, S.-R., Binley, K., Pata, I., Doi, K., Mannik, J., Zernant-Rajang, J., Kan, O., Iqball, S., Naylor, S., et al. (2008) · Gene Therapy · doi:10.1038/gt.2008.78 · Cited by 215
Follenzi, A., Battaglia, M., Lombardo, A., Annoni, A., Roncarolo, M. G., & Naldini, L. (2004) · Blood · doi:10.1182/blood-2003-09-3217 · Cited by 212
Vandendriessche, T., Thorrez, L., Acosta‐Sanchez, A., Petrus, I., Wang, L., Ma, L., De Waele, L., Iwasaki, Y., Gillijns, V., Wilson, J. M., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02220.x · Cited by 209
Self-citationLentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy
Azzouz, M., Le, T., Ralph, G. S., Walmsley, L., Monani, U. R., Lee, D. C. P., Wilkes, F., Mitrophanous, K. A., Kingsman, S. M., Burghes, A. H. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422922 · Cited by 209
Continuous high-titer HIV-1 vector production
Ikeda, Y., Takeuchi, Y., Martin, F., Cosset, F.-L., Mitrophanous, K., & Collins, M. (2003) · Nature Biotechnology · doi:10.1038/nbt815 · Cited by 198
Watson, D. J., Kobinger, G. P., Passini, M. A., Wilson, J. M., & Wolfe, J. H. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0584 · Cited by 198
Bainbridge, J., Stephens, C., Parsley, K., Demaison, C., Halfyard, A., Thrasher, A., & Ali, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301574 · Cited by 197
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Nightingale, S. J., Hollis, R. P., Pepper, K. A., Petersen, D., Yu, X.-J., Yang, C., Bahner, I., & Kohn, D. B. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.008 · Cited by 192
Shi, Q. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28416 · Cited by 191
Brown, B. D., Sitia, G., Annoni, A., Hauben, E., Sergi, L. S., Zingale, A., Roncarolo, M. G., Guidotti, L. G., & Naldini, L. (2007) · Blood · doi:10.1182/blood-2006-10-049312 · Cited by 188
Production and Titration of Lentiviral Vectors
Salmon, P., & Trono, D. (2007) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1210s54 · Cited by 185
Wong, L.-F., Goodhead, L., Prat, C., Mitrophanous, K. A., Kingsman, S. M., & Mazarakis, N. D. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1 · Cited by 184
Zhang, F., Thornhill, S. I., Howe, S. J., Ulaganathan, M., Schambach, A., Sinclair, J., Kinnon, C., Gaspar, H. B., Antoniou, M., & Thrasher, A. J. (2007) · Blood · doi:10.1182/blood-2006-12-060814 · Cited by 176
Stable Gene Transfer to Muscle Using Non-integrating Lentiviral Vectors
Apolonia, L., Waddington, S. N., Fernandes, C., Ward, N. J., Bouma, G., Blundell, M. P., Thrasher, A. J., Collins, M. K., & Philpott, N. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300281 · Cited by 174
A Phase I/II Clinical Trial of β‐Globin Gene Therapy for β‐Thalassemia
BANK, A., DORAZIO, R., & LEBOULCH, P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.007 · Cited by 169
Generation of a Stable Cell Line Producing High-Titer Self-Inactivating Lentiviral Vectors
Xu, K., Ma, H., McCown, T. J., Verma, I. M., & Kafri, T. (2001) · Molecular Therapy · doi:10.1006/mthe.2000.0238 · Cited by 168
Frecha, C., Costa, C., Nègre, D., Gauthier, E., Russell, S. J., Cosset, F.-L., & Verhoeyen, E. (2008) · Blood · doi:10.1182/blood-2008-05-155945 · Cited by 164
Targeting lentiviral vectors to specific cell types in vivo
Yang, L., Bailey, L., Baltimore, D., & Wang, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604993103 · Cited by 161
Throm, R. E., Ouma, A. A., Zhou, S., Chandrasekaran, A., Lockey, T. D., Greene, M. R., Ravin, S. S. D., Moayeri, M., Malech, H. L., Sorrentino, B. P., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191049 · Cited by 154
Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells
VandenDriessche, T., Ivics, Z., Izsvák, Z., & Chuah, M. (2009) · Blood · doi:10.1182/blood-2009-04-210427 · Cited by 152
Self-citationManilla, P., Rebello, T., Afable, C., Lü, X., Slepushkin, V., Humeau, L. M. P. F., Schonely, K., Ni, Y., Binder, G. K., Levine, B. L., et al. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.17 · Cited by 149
Vigna, E., Cavalieri, S., Ailles, L., Geuna, M., Loew, R., Bujard, H., & Naldini, L. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0542 · Cited by 147
Broussau, S., Jabbour, N., Lachapelle, G., Durocher, Y., Tom, R. L., Transfiguracion, J. C., Gilbert, R., & Massie, B. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300383 · Cited by 146
Transduction Patterns of Pseudotyped Lentiviral Vectors in the Nervous System
Wong, L., Azzouz, M., Walmsley, L. E., Askham, Z., Wilkes, F. J., Mitrophanous, K. A., Kingsman, S. M., & Mazarakis, N. D. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.09.017 · Cited by 145
Lentiviral Vectors for Use in the Central Nervous System
Jakobsson, J., & Lundberg, C. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.012 · Cited by 133
Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Lundberg, C., Björklund, T., Carlsson, T., Jakobsson, J., Hantraye, P., Déglon, N., & Kirik, D. (2008) · Current Gene Therapy · doi:10.2174/156652308786847996 · Cited by 133
Lentivirus‐mediated platelet‐derived factor VIII gene therapy in murine haemophilia A
Shi, Q., Wilcox, D. A., Fahs, S. A., Fang, J., JOHNSON, B. D., Du, L. M., DESAI, D., & Montgomery, R. R. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02346.x · Cited by 132
Bemelmans, A., Kostic, C., Crippa, S. V., Hauswirth, W. W., Lem, J., Munier, F. L., Seeliger, M. W., Wenzel, A., & Arsenijévic, Y. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030347 · Cited by 121
Verhoeyen, E., Dardalhon, V., Ducrey, O., Trono, D., Taylor, N. N., & Cosset, F. (2003) · Blood · doi:10.1182/blood-2002-07-2224 · Cited by 121
Insertional mutagenesis in gene therapy and stem cell biology
Baum, C. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3281900f01 · Cited by 118
Hanawa, H., Hargrove, P. W., Kepes, S., Srivastava, D. K., Nienhuis, A. W., & Persons, D. A. (2004) · Blood · doi:10.1182/blood-2004-03-0863 · Cited by 116
Pfeifer, A., Keßler, T., Yang, M., Baranov, E., Kootstra, N. A., Cheresh, D. A., Hoffman, R. M., & Verma, I. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0276 · Cited by 116
Bonci, D., Cittadini, A., Latronico, M. V. G., Borello, U., Aycock, J., Drusco, A., Innocenzi, A., Follenzi, A., Lavitrano, M., Monti, M. G., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301936 · Cited by 116
Hargrove, P. W., Kepes, S., Hanawa, H., Obenauer, J. C., Pei, D., Cheng, C., Gray, J. T., Neale, G. A. M., & Persons, D. A. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300394 · Cited by 113
Maurice, M., Verhoeyen, E., Salmon, P., Trono, D., Russell, S. J., & Cosset, F. (2002) · Blood · doi:10.1182/blood.v99.7.2342 · Cited by 107
Rahim, A. A., Wong, A. M. S., Howe, S. J., Buckley, S. M. K., Acosta-Saltos, A. D., Elston, K. E., Ward, N. J., Philpott, N. J., Cooper, J. D., Anderson, P. N., et al. (2009) · Gene Therapy · doi:10.1038/gt.2008.186 · Cited by 101
Downstream processing of oncoretroviral and lentiviral gene therapy vectors
Segura, M. M., Kamen, A., & Garnier, A. (2006) · Biotechnology Advances · doi:10.1016/j.biotechadv.2005.12.001 · Cited by 97
Hybrid Lentivirus-transposon Vectors with a Random Integration Profile in Human Cells
Staunstrup, N. H., Moldt, B., Mátés, L., Villesen, P., Jakobsen, M., Ivics, Z., Izsvák, Z., & Mikkelsen, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.10 · Cited by 96
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16
Modlich, U., Schambach, A., Brugman, M. H., Wicke, D. C., Knoess, S., Li, Z., Maetzig, T., Rudolph, C., Schlegelberger, B., & Baum, C. (2008) · Leukemia · doi:10.1038/leu.2008.118 · Cited by 96
Naldini, L., & Verma, I. M. (2000) · Advances in virus research · doi:10.1016/s0065-3527(00)55020-9 · Cited by 96
A Large U3 Deletion Causes Increased In Vivo Expression from a Nonintegrating Lentiviral Vector
Bayer, M., Kantor, B., Cockrell, A., Ma, H., Zeithaml, B., Li, X., McCown, T., & Kafri, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.199 · Cited by 94
Fleury, S., Simeoni, E., Zuppinger, C., Déglon, N., von Segesser, L. K., KAPPENBERGER, L. J., & Vassalli, G. (2003) · Circulation · doi:10.1161/01.cir.0000065598.46411.ef · Cited by 92
Meyer, S. D. D., Vanhoorelbeke, K., Chuah, M., Pareyn, I., Gillijns, V., Hebbel, R., Collen, D., Deckmyn, H., & VandenDriessche, T. (2006) · Blood · doi:10.1182/blood-2005-09-3605 · Cited by 91
Self-citationUse of Nonintegrating Lentiviral Vectors for Gene Therapy
Philpott, N. J., & Thrasher, A. J. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.013 · Cited by 90
Stein, C. S., Kang, Y., Sauter, S. L., Townsend, K., Staber, P. D., Derksen, T. A., Martins, I., Qian, J., Davidson, B. L., & McCray, P. B. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0325 · Cited by 89
Logan, A. C., Haas, D. L., Kafri, T., & Kohn, D. B. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8421-8436.2004 · Cited by 89
Zielske, S. P., Reese, J., Lingas, K. T., Donze, J. R., & Gerson, S. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17922 · Cited by 87
Karwacz, K., Mukherjee, S., Apolonia, L., Blundell, M. P., Bouma, G., Escors, D., Collins, M. K., & Thrasher, A. J. (2009) · Journal of Virology · doi:10.1128/jvi.02519-08 · Cited by 87
Immune Responses to Lentiviral Vectors
Follenzi, A., Santambrogio, L., & Annoni, A. (2007) · Current Gene Therapy · doi:10.2174/156652307782151515 · Cited by 87
Miyazaki, M., Ikeda, Y., Yonemitsu, Y., Goto, Y., Sakamoto, T., Tabata, T., Ueda, Y., Hasegawa, M., Tobimatsu, S., Ishibashi, T., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302028 · Cited by 85
Clinical Application of Lentiviral Vectors – Concepts and Practice
Schambach, A., & Baum, C. (2008) · Current Gene Therapy · doi:10.2174/156652308786848049 · Cited by 84
Arumugam, P. I., Higashimoto, T., Urbinati, F., Modlich, U., Nestheide, S. V., Xia, P., Fox, C. F., Corsinotti, A., Baum, C., & Malik, P. (2009) · Molecular Therapy · doi:10.1038/mt.2009.183 · Cited by 81
Ryu, B. Y., Evans‐Galea, M. V., Gray, J. T., Bodine, D. M., Persons, D. A., & Nienhuis, A. W. (2007) · Blood · doi:10.1182/blood-2007-04-085506 · Cited by 81
Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer
Kang, Y., Xie, L., Tran, D. T., Stein, C. S., Hickey, M. A., Davidson, B. L., & McCray, P. B. (2005) · Blood · doi:10.1182/blood-2004-11-4358 · Cited by 78
Sleeping Beauty Transposition From Nonintegrating Lentivirus
Vink, C. A., Gaspar, H. B., Gabriel, R., Schmidt, M., McIvor, R. S., Thrasher, A. J., & Qasim, W. (2009) · Molecular Therapy · doi:10.1038/mt.2009.94 · Cited by 78
Stem cell–derived erythroid cells mediate long-term systemic protein delivery
Chang, A. H., Stephan, M. T., & Sadelain, M. (2006) · Nature Biotechnology · doi:10.1038/nbt1227 · Cited by 75
Kutner, R. H., Puthli, S., Marino, M. P., & Reiser, J. (2009) · BMC Biotechnology · doi:10.1186/1472-6750-9-10 · Cited by 72
Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine
Coutant, F., Frenkiel, M.-P., Despres, P., & Charneau, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003973 · Cited by 70
Pike‐Overzet, K., de Ridder, D., Weerkamp, F., Baert, M. R. M., Verstegen, M. M. A., Brugman, M. H., Howe, S. J., Reinders, M. J. T., Thrasher, A. J., Wagemaker, G., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404563 · Cited by 70
Lentiviral vectors with measles virus glycoproteins – dream team for gene transfer?
Buchholz, C. J., Mühlebach, M. D., & Cichutek, K. (2009) · Trends in biotechnology · doi:10.1016/j.tibtech.2009.02.002 · Cited by 70
A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors
Cockrell, A. S., Ma, H., Fu, K., McCown, T. J., & Kafri, T. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.12.015 · Cited by 62
Lentiviral vectors in clinical trials: Current status.
D’Costa, J., Mansfield, S. G., & Humeau, L. M. P. F. (2009) · PubMed · Cited by 60
Papapetrou, E. P., Kovalovsky, D., Beloeil, L., Sant’Angelo, D. B., & Sadelain, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37216 · Cited by 60
Development of lentiviral gene therapy for Wiskott Aldrich syndrome
Galy, A. H. M., Roncarolo, M., & Thrasher, A. J. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.2.181 · Cited by 59
Mobilization and Mechanism of Transcription of Integrated Self-Inactivating Lentiviral Vectors
Hanawa, H., Persons, D. A., & Nienhuis, A. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8410-8421.2005 · Cited by 55
Future of cell and gene therapies for Parkinson's disease
Ole Isacson, A., & Kordower, J. H. (2009) · Annals of Neurology · doi:10.1002/ana.21473 · Cited by 55
Cartier, N., & Aubourg, P. A. (2008) · PubMed · Cited by 54
Wang, D., Zhang, W., Kalfa, T. A., Grabowski, G. A., Davies, S. M., Malik, P., & Pan, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908528106 · Cited by 51
Müller, N., Avota, E., Schneider‐Schaulies, J., Harms, H., Krohne, G., & Schneider‐Schaulies, S. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00426.x · Cited by 50
In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.
Adjali, O., Marodon, G., Steinberg, M., Mongellaz, C., Thomas-Vaslin, V., Jacquet, C., Taylor, N., & Klatzmann, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23966 · Cited by 46
Manfredsson, F. P., Okun, M. S., & Mandel, R. J. (2009) · Current Gene Therapy · doi:10.2174/156652309789753400 · Cited by 46
Worsham, D. N., Schuesler, T., Kalle, C. V., & Pan, D. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.014 · Cited by 44
Microglia: a cellular vehicle for CNS gene therapy
Neumann, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30230 · Cited by 41
Trono, D. (2003) · Science · doi:10.1126/science.1086238 · Cited by 40
Gene Therapy of Storage Disorders by Retroviral and Lentiviral Vectors
Biffi, A., & Naldini, L. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1133 · Cited by 39
Sirin, O., & Park, F. (2003) · Gene · doi:10.1016/j.gene.2003.09.006 · Cited by 39
It's all about the clothing: capsid domination in the adeno‐associated viral vector world
Arruda, V. R., & Xiao, W. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02262.x · Cited by 36
Annoni, A., Battaglia, M., Follenzi, A., Lombardo, A., Sergi, L. S., Naldini, L., & Roncarolo, M. (2007) · Blood · doi:10.1182/blood-2006-11-059873 · Cited by 36
Frecha, C. A., Toscano, M. G., Costa, C., Sáez‐Lara, M. J., Cosset, F., Verhoeyen, E., & Martín, F. (2008) · Gene Therapy · doi:10.1038/gt.2008.20 · Cited by 35
Current status of globin gene therapy for the treatment of β‐thalassaemia
Lisowski, L., & Sadelain, M. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07098.x · Cited by 34
Development of Ecdysone-Regulated Lentiviral Vectors
Galimi, F., Sáez, E., Gall, J. G. D., Hoong, N., Cho, G., Evans, R. M., & Verma, I. M. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.021 · Cited by 33
Development and Applications of Non-HIV-Based Lentiviral Vectors in Neurological Disorders
Valori, C. F., Ning, K., Wyles, M., & Azzouz, M. (2008) · Current Gene Therapy · doi:10.2174/156652308786848030 · Cited by 33
Gene Therapy for ALS: Progress and prospects
Azzouz, M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.003 · Cited by 33
Targeting Lentiviral Vectors to Antigen-Specific Immunoglobulins
Ziegler, L., Yang, L., Joo, K. I., Yang, H., Baltimore, D., & Wang, P. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.149 · Cited by 32
Pan, Y.-W., Scarlett, J. M., Luoh, T. T., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01089-06 · Cited by 32
Cornils, K., Lange, C., Schambach, A., Brugman, M. H., Nowak, R., Lioznov, M. V., Baum, C., & Fehse, B. (2008) · Molecular Therapy · doi:10.1038/mt.2008.238 · Cited by 31
Beard, B. C., Sud, R., Keyser, K. A., Ironside, C. M., Neff, T., Gerull, S., Trobridge, G. D., & Kiem, H. (2009) · Blood · doi:10.1182/blood-2008-09-176412 · Cited by 27
Lentiviral vectors for HIV disease prevention and treatment
Lemiale, F., & Korokhov, N. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.055 · Cited by 24
Gene Delivery to the Retina Using Lentiviral Vectors
Greenberg, K. P., Lee, E. S., Schaffer, D. V., & Flannery, J. G. (2007) · Springer eBooks · doi:10.1007/0-387-32442-9_36 · Cited by 24
Towards gene therapy for Parkinson's disease
Palfi, S. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70066-8 · Cited by 22
Reducing mobilization of simian immunodeficiency virus based vectors by primer complementation
Grünwald, T., Pedersen, F. S., Wagner, R., & Überla, K. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.479 · Cited by 19
Bukrinsky, M. (2008) · Retrovirology · doi:10.1186/1742-4690-5-85 · Cited by 16
Sadelain, M., Chang, A. H., & Lisowski, L. (2009) · Molecular Therapy · doi:10.1038/mt.2009.238 · Cited by 13
Leuci, V., Gammaitoni, L., Capellero, S., Sangiolo, D., Mesuraca, M., Bond, H. M., Migliardi, G., Cammarata, C., Aglietta, M., Morrone, G., et al. (2009) · Stem Cells · doi:10.1002/stem.224 · Cited by 11
A new direction for gene therapy: intrathymic T cell-specific lentiviral gene transfer
Seggewiss, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26041 · Cited by 11
Lentiviral Gene Transfer-Mediated Cone Vision Restoration in RPE65 Knockout Mice
Bemelmans, A., Kostic, C., Cachafeiro, M. C. B., Crippa, S. V., Wanner, D., Tekaya, M., Wenzel, A., & Arsenijévic, Y. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74904-4_9 · Cited by 8
VandenDriessche, T. (2009) · Blood · doi:10.1182/blood-2009-07-228510 · Cited by 7
Self-citation
Cited by
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
Finkelshtein, D., Werman, A., Novick, D., Barak, S., & Rubinstein, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214441110 · Cited by 656
Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
(2013) · PubMed · Cited by 308
Prommersberger, S., Reiser, M., Beckmann, J., Danhof, S., Amberger, M., Quade-Lyssy, P., Einsele, H., Hudecek, M., Bonig, H., & Ivics, Z. (2021) · Gene Therapy · doi:10.1038/s41434-021-00254-w · Cited by 182
Metadata
- Authors
- Mátrai, J., Chuah, M. K., & VandenDriessche, T.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 18
- Issue
- 3
- Pages
- 477-490
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2036867468
- Cited by
- 347
- References
- 170
- FWCI
- 19.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.